| A new parameter in COVID-19 pandemic: initial lactate dehydrogenase (LDH)/Lymphocyte ratio for diagnosis and mortality I Serin, ND Sari, MH Dogu, SD Acikel, G Babur, A Ulusoy, MI Onar, ... Journal of infection and public health 13 (11), 1664-1670, 2020 | 26 | 2020 |
| Serum Aspergillus galactomannan lateral flow assay for the diagnosis of invasive aspergillosis: A single‐centre study I Serin, MH Dogu Mycoses 64 (6), 678-683, 2021 | 12 | 2021 |
| Investigation of MBL2 and NOS3 functional gene variants in suspected COVID-19 PCR (–) patients S Pehlivan, M Köse, S Mese, I Serin, N Senkal, Y Oyacı, ... Pathogens and global health 116 (3), 178-184, 2022 | 9 | 2022 |
| Prognostic role of lymphocyte/monocyte ratio in chronic lymphocytic leukemia O Yokus, EN Saglam, H Goze, F Sametoglu, I Serin Journal of Hematology 9 (4), 116, 2020 | 8 | 2020 |
| Enigma of COVID-19: is “multisystem inflammatory syndrome in adults”(MIS-A) predictable? I Serin, ND Sari, M Gunaltili, A Karakilic, B Gulesir, B Kal Kolik, G Cevik, ... BMC Infectious Diseases 22 (1), 300, 2022 | 5 | 2022 |
| The Real‐World Experience With Single Agent Ibrutinib in Relapsed/Refractory CLL S Akpinar, MH Dogu, S Celik, O Ekinci, IY Hindilerden, MS Dal, ... Clinical Lymphoma Myeloma and Leukemia 22 (3), 169-173, 2022 | 5 | 2022 |
| Iron overload during the treatment of acute leukemia: pretransplant transfusion experience O Yokus, C Herek, TA Cinli, H Goze, I Serin International Journal of Hematologic Oncology 10 (3), IJH36, 2021 | 5 | 2021 |
| A new parameter in multiple myeloma: CYP3A4* 1B single nucleotide polymorphism I Serin, S Pehlivan, I Gundes, Y Fidan Oyaci, M Pehlivan Annals of Hematology 100, 421-427, 2021 | 5 | 2021 |
| Lenalidomide plus decitabine treatment in a myelodysplastic syndrome patient with deletion 5q and excess blasts I Serin, R Eren, MH Dogu Journal of Hematology 9 (1-2), 33, 2020 | 5 | 2020 |
| Lateral flow assay (LFA) in the diagnosis of COVID-19-associated pulmonary aspergillosis (CAPA): a single-center experience I Serin, S Baltali, TA Cinli, H Goze, B Demir, O Yokus BMC Infectious Diseases 22 (1), 822, 2022 | 4 | 2022 |
| First-line usage of daratumumab, lenalidomide, dexamethasone (DRd) combination in a case of castleman disease variant of polyneuropathy, organomegaly, endocrinopathy … OG Sevindik, YG Mutlu, BB Aydin, I Serin HemaSphere 6 (7), e728, 2022 | 4 | 2022 |
| A real-life Turkish experience of venetoclax treatment in high-risk myelodysplastic syndrome and acute myeloid leukemia A Gemici, F Ozkalemkas, MH Dogu, A Tekinalp, I Alacacioglu, T Guney, ... Clinical Lymphoma Myeloma and Leukemia 21 (8), e686-e692, 2021 | 4 | 2021 |
| Evaluation of Intraventricular/Intrathecal Antimicrobial Therapy in the Treatment of Nosocomial Meningitis Caused by Multidrug‐Resistant Gram‐Negative Bacteria after Central … ND Sari, S Baltali, I Serin, V Antar Canadian Journal of Infectious Diseases and Medical Microbiology 2021 (1 …, 2021 | 4 | 2021 |
| Recurrence of lymphoma with isolated pericardial mass: a case report I Serin, A Ulusoy, MI Onar, MH Dogu Journal of Medical Case Reports 14, 1-5, 2020 | 4 | 2020 |
| The effect of DNA repair gene variants on COVID-19 disease: susceptibility, severity, and clinical course N Senkal, I Serin, S Pehlivan, M Pehlivan, A Medetalibeyoglu, T Cebeci, ... Nucleosides, Nucleotides & Nucleic Acids 42 (8), 571-585, 2023 | 3 | 2023 |
| Serum albumin and ferritin levels: a practical indicator of prognosis in acute myeloid leukemia over 50 years of age? O Yokus, E Sunger, TA Cinli, H Goze, I Serin American Journal of Blood Research 12 (3), 97, 2022 | 3 | 2022 |
| Hemolytic anemia and plasma exchange I Serin, MH Dogu Transfusion and Apheresis Science 60 (5), 103245, 2021 | 3 | 2021 |
| Medication-related osteonecrosis of the jaw (MRONJ) and eNOS Polymorphisms in multiple myeloma patients: a single center experience B Taş Ozyurtseven, I Serin, AF Nursal, S Pehlivan, M Pehlivan BMC Oral Health 21 (1), 272, 2021 | 3 | 2021 |
| The miRNA 196a2 rs11614913 variant has prognostic impact on Turkish patients with multiple myeloma MP Kirik, M Pehlivan, AF Nursal, Y Oyaci, S Pehlivan, I Serin BMC research notes 13, 1-6, 2020 | 3 | 2020 |
| The outcomes of chronic myeloid leukemia patients with molecular warning responses during imatinib treatment according to the European LeukemiaNet 2013 recommendations T Soysal, AE Eskazan, I Serin, S Sadri, D Keskin, NO Yurttas, S Berk, ... Clinical Lymphoma Myeloma and Leukemia 19 (7), e377-e384, 2019 | 3 | 2019 |
